Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New booster shot shows promise for vulnerable patients

NCT ID NCT06027229

First seen Nov 01, 2025 · Last updated Jun 02, 2026 · Updated 30 times

Summary

This study looked at whether an extra COVID-19 booster shot can strengthen the immune response in people with weakened immune systems, such as those with inflammatory bowel disease or organ transplant recipients. About 21 participants received the booster and were monitored for 6 months. The goal was to see if antibody levels increased after the shot.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UW School of Medicine and Public Health

    Madison, Wisconsin, 53792, United States

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.